Hana Pharm Co., Ltd.
KRX:293480.KS
11350 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 22,332.77 | 24,307.179 | 28,013.836 | 14,892.865 | 28,303.725 | 26,169.074 | 24,302.486 | 17,430.848 | 4,911.356 |
| Depreciation & Amortization
| 7,579.849 | 6,494.843 | 5,761.91 | 4,995.134 | 4,200.735 | 3,562.764 | 3,521.674 | 3,677.928 | 3,901.037 |
| Deferred Income Tax
| 0 | 0 | 0 | 372.198 | -670.158 | 0 | 0 | -560.667 | -1,016.506 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -11,979.942 | -1,777.822 | -11,034.881 | -2,696.969 | -3,018.945 | -864.975 | -3,655.21 | -8,005.102 | -1,875.916 |
| Accounts Receivables
| -1,659.643 | -1,602.928 | 778.798 | -1,244.42 | 579.73 | 267.385 | -3,461.137 | -8,184.414 | -9,621.812 |
| Inventory
| -6,943.757 | -710.847 | -9,962.778 | -3,843.915 | -4,879.987 | -2,736.104 | -1,243.3 | -3,640.842 | -372.419 |
| Accounts Payables
| -1,605.841 | 1,431.881 | 644.09 | -905.143 | -579.73 | -1,014.869 | 444.72 | 574.967 | 1,256.043 |
| Other Working Capital
| -1,770.7 | -895.928 | -2,494.99 | 3,296.509 | 1,861.042 | 1,871.129 | -2,411.91 | -4,364.26 | 6,862.272 |
| Other Non Cash Items
| 471.029 | 1,859.323 | 2,914.193 | -1,611.142 | 2,231.603 | -1,280.299 | 1,211.217 | -639.739 | 18,459.737 |
| Operating Cash Flow
| 18,403.707 | 30,883.523 | 25,655.058 | 15,579.888 | 31,717.117 | 27,586.564 | 25,380.167 | 12,463.935 | 7,839.446 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -14,683.402 | -35,771.449 | -34,810.152 | -17,140.501 | -33,732.039 | -5,570.859 | -3,842.341 | -9,996.725 | -3,306.349 |
| Acquisitions Net
| 92.636 | 277.455 | -224.068 | -1,659.788 | -325.974 | -357.191 | 360 | -18.215 | 54.181 |
| Purchases Of Investments
| -11,886.738 | -28,174.816 | -61,698.007 | -63,646.484 | -116,144.053 | -198,756.918 | -9,762.095 | -7,837.588 | -6,585.998 |
| Sales Maturities Of Investments
| 11,496.743 | 57,607.262 | 60,978.537 | 81,569.835 | 131,323.66 | 113,057.07 | 7,920 | 8,800 | 6,362 |
| Other Investing Activites
| 3,086.532 | -30,446.03 | 257.351 | 34.471 | -180.419 | -6,299.819 | -7,493.766 | -257.017 | -793.545 |
| Investing Cash Flow
| -11,894.229 | -36,507.579 | -35,496.339 | -842.468 | -19,058.825 | -97,927.717 | -12,818.202 | -9,309.544 | -4,269.71 |
| Financing Activities: | |||||||||
| Debt Repayment
| -7,006.62 | -13,354.493 | -1,446.8 | -690.679 | -17,890.227 | -25,060.147 | -3,385.863 | -11,612.139 | -4,302.62 |
| Common Stock Issued
| 0 | 0 | 6,034.204 | 0 | 15,692.648 | 104,083.904 | 1,891.847 | 1,861.675 | 1,808.8 |
| Common Stock Repurchased
| 0 | 0 | -65.116 | 0 | -8,352.845 | -2,497.07 | 1,505.878 | 0 | 0 |
| Dividends Paid
| -8,822.738 | -8,822.738 | -8,022.025 | -7,235.552 | -4,507.84 | -3,005.398 | -1,023.212 | 0 | -2.462 |
| Other Financing Activities
| -1,805.899 | 33,734.187 | -590 | -1,233.272 | 396.041 | 868.091 | 0.805 | 7,416.814 | -674.536 |
| Financing Cash Flow
| -17,635.257 | 11,556.956 | -4,089.737 | -9,159.503 | -14,662.222 | 74,389.38 | -1,010.546 | -2,333.65 | -3,170.818 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 2.288 | -0.002 | -0.199 | -16.02 | 0 | -0 | 0 | 0 | 0 |
| Net Change In Cash
| -11,123.492 | 5,932.898 | -13,931.217 | 5,561.897 | -2,003.93 | 4,048.227 | 11,551.419 | 820.741 | 398.918 |
| Cash At End Of Period
| 1,424.616 | 12,548.107 | 6,615.209 | 20,546.426 | 14,984.529 | 16,988.458 | 12,940.232 | 1,388.813 | 568.072 |